Format

Send to

Choose Destination
Oncology (Williston Park). 1994 Sep;8(9):37-42; discussion 44-5, 50-2, 61.

Has combined modality therapy improved the outlook in carcinoma of the esophagus?

Author information

1
Division of Medicine, University of Texas M.D. Anderson Cancer Center Houston.

Abstract

Carcinoma of the esophagus or the gastroesophageal junction is uncommon, accounting for approximately 1% of all malignancies in the United States. Approximately 11,000 new cases and 10,400 deaths are estimated in 1994. The diagnosis is often made late in Western countries, thus T3, T4, and N-positive lesions are encountered frequently. Nearly 50% of patients have advanced incurable disease at the time of diagnosis. Therefore, the prognosis of patients with carcinoma of the esophagus remains poor and the overall 5-year survival rates are still under 10%. The answer to the question in the title is yes, at least for some patients, on a short-term basis.

PMID:
7527642
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center